Litcius/Paper detail

Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer

Zhengyang Wu, Ying Bai, Jiaming Jin, Teng Jiang, Hui Shen, Qiurong Ju, Qihua Zhu, Yungen Xu

2021European Journal of Medicinal Chemistry31 citationsDOIOpen Access PDF

Topics & Concepts

Poly ADP ribose polymerasePI3K/AKT/mTOR pathwayChemistryPARP inhibitorCardiotoxicityIn vivoCancerIC50PharmacologyCancer researchIn vitroPolymeraseBiochemistryMedicineInternal medicineSignal transductionBiologyEnzymeToxicityGeneticsOrganic chemistryPARP inhibition in cancer therapyDNA Repair MechanismsCRISPR and Genetic Engineering
Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer | Litcius